While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

Novo Nordisk’s Saxenda has been recommended by NICE as a treatment for obesity, ending a 10-year drought in new drug therapies for weight management. The cost-effectiveness agency for England ...

Currently, there are six FDA approved weight loss medications. They include three GLP-1 receptor agonists -- liraglutide ...

A large majority of older Americans feel that health insurance – including Medicare – should cover anti-obesity medications, according to a new University of Michigan study.

A large majority of older Americans feel that health insurance—including Medicare—should cover anti-obesity medications, ...

Employers, including Express Scripts parent company Cigna, seek to manage GLP-1 costs through programs administered by the ...

According to the Ministry of Food and Drug Safety, the number of patients prescribed methylphenidate, an ADHD medication, was ...

The number of patients prescribed appetite suppressants has been shown to have decreased continuously. According to the ...